PCI 7 November 2023, 15:22
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46

Current Edition

Cell and Gene Therapy

Upcoming Events

NextGen BioMed – 04/02/2025
BioTrinity 2025 – January 30th 2025
Elrig R&I 2025 – 27th January 2025
Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault: Wed 17 July 2024, 11:46
Aurisco – 04/02/2025

Opening of Biosynth Biological Technology; a New Cutting-Edge Facility at Lifebay in Suzhou, China.

(For a high-resolution image please contact AshleyH@alto-marketing.com)

Specialising in supporting biological science, these state-of-the-art facilities significantly enhance capabilities for internal project initiatives and material supply.

Biosynth, a leading developer and supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceutical industries, is pleased to announce the opening of their Biosynth Biological Technology site at Lifebay, an innovative technology park in Suzhou, China. This new site houses state-of-the-art facilities including a Bio-laboratory which significantly enhances capabilities for internal project development initiatives and material supply into the domestic Life Science market.

The official opening ceremony on 29th October was attended by local and national dignitaries, Life Science and Pharma customers, and partners of Biosynth as well as representatives of Biosynth’s Leadership Team along with Board Representative Nico Haller, Director at KKR.

Dr. Thomas Eisele, Chief Operations Officer, announced, We are thrilled to be formally opening Biosynth Biological Technology. This facility represents our dedication to innovation and excellence and adds a crucial production site for internal materials as well as acting as a distribution and handling hub for our customers in the region.”

Philip Noone, Chief Commercial Officer, commented, “Through our new Lifebay facility in Suzhou, Biosynth will serve IVD companies across China directly, with our comprehensive Biologics, Chemicals, and Complex Peptides offering. Our new site will allow us for the first time in our history to offer our unique diagnostic solutions for infectious diseases, oncology, and autoimmunity targeting emerging pathogens.”

Alessandra Vismara, General Manager for China, added, “This has been a significant project to build and equip this facility. As part of the next phase, we will be commissioning our biosafety level 2 laboratories, which means that we can handle and supply even more biological diagnostic tools. Enzyme development and production for local customers will complete the portfolio of these facilities.”

Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40